The HLA complex P5 (HCP5) is a cancer-related lncRNA and has been investigated in breast cancer22, follicular thyroid carcinoma (FTC)23, lung adenocarcinoma (LUAD)24, glioma25, and GC26. Here, HCP5 is linked to thyroid cancer, nonmedullary, 2.